DFDA

Surgical Excision / Electrocautery / Laser Ablation

Treatment for Hpv Infection

Typical Dosage: Surgical removal of lesions

Effectiveness
95%
Safety Score
78%
Clinical Trials
2
Participants
7.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
78
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical removal of lesions
Time to Effect
Immediate clearance, 1-4 weeks healing
Treatment Duration
Single procedure, 1-4 weeks healing
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,700
Side Effect Mgmt:$150
Total Annual:$1,850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
Outcome-Based Costs
Cost per Responder
$1,947
Cost per Remission
$1,947
Comparison vs Cryotherapy
Cost Difference
+$800/year
More expensive
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Surgical Excision / Electrocautery / Laser Ablation Outcomes

for Hpv Infection

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Pain
+70%
Scarring
+40%
Infection
+10%
Bleeding
+7%
Dyspigmentation
+15%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
2 completed trials for Surgical Excision / Electrocautery / Laser Ablation in Hpv Infection

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

NCT02520986COMPLETEDNA
View Study
140 participants
INTERVENTIONAL
Herne, Germany
Started: Oct 25, 2016

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

NCT02135419COMPLETEDPHASE3
View Study
4.45K participants
INTERVENTIONAL
Los Angeles, United States +24 more
Started: Sep 24, 2014